As polβ-deficient ovarian cancer cells are not only sensitive to platinum treatment but also show features of replication stress as evidenced by accumulation of ATR and pChk1ser 345, we tested a synthetic lethality application for either PARPi or PARGi. The gene discussed is POLB; the disease is ovarian cancer.